Dr Theodore Hong is the Director of Gastrointestinal Radiation Oncology and Associate Clinical Director at Massachusetts General Hospital and Associate Professor of Radiation Oncology at Harvard Medical School. He graduated from Harvard College and University of Connecticut School of Medicine. He completed his residency in radiation oncology at the University of Wisconsin. He started at MGH in 2005, and actively sees patients in the Gastrointestinal Cancer Center. He completed the MGPO Leadership Development Course in 2009. He has been a member of the MGPO Executive Committee from 2011-2017. In 2017, he was elected to the MGPO Board of Trustees. His research interests include proton therapy, targeted therapies, immunotherapy, and biomarker development for GI cancers. He is the principal investigator of the MGH-MD Anderson Proton Program Project Grant. He serves on the NCI task force for hepatobiliary cancer and colon cancer, and is co-chair of the rectal-anal task force. He is the Principal Investigator numerous investigator initiated trials and of two national cooperative group trials: NRG GI-001, the first phase III trial specific to intrahepatic cholangiocarcinoma performed by the United States cooperative group system and NRG GI-003, a randomized trial of protons vs photons in hepatocellular carcinoma. He is 2014-2016 Dana Farber/Harvard Cancer Center recipient of the NCI Cancer Clinical Investigator Team Leadership Award and in 2017 was appointed Co-Leader of the Dana-Farber/Harvard Cancer Center Gastrointestinal Malignancies Research Program.
Abstracts this author is presenting: